Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, AR

Clinical Trial Details

Overview

Research Study Summary

If you have RA and have had an inadequate response to a TNF-a inhibitor, contact us today!

Purpose

The purpose of this research study is to find out the effectiveness and safety of 2 different doses of a new study drug in subjects with RA who have had an inadequate response to a TNF-a inhibitor.

Patient Inclusion Criteria:

  • Males or females =18 years of age.
  • Diagnosis of adult-onset RA of at least 6 months
  • Patients must have been treated at approved doses with at least one biologic TNF-a inhibitor therapy
  • Regular use of at least one conventional DMARD
  • Women must not be pregnant, breastfeeding, or at risk to become pregnant during study participation.

Patient Exclusion Criteria:

  • Have had surgical treatment within 60 days of a joint that is to be assessed in the study or will require such treatment during the study.
  • Have had any major surgery within 60 days, or will require such during the study.
  • Have active fibromyalgia or have a diagnosis of any systemic inflammatory condition other than RA
  • Have had any malignancy within the past 5 years, except for cervical carcinoma in situ that has been resected with no evidence of recurrence or metastatic disease, or basal cell or squamous epithelial skin cancers that were completely resected and have no evidence of recurrence for at least three years.
  • Are positive for human immunodeficiency virus (HIV).
  • Have had a serious infection (e.g., pneumonia, cellulitis) within 3 months of baselineor had serious bone or joint infections within 6 months
  • Have an active or recent infection (including symptomatic herpes zoster or herpes simplex) within 30 days
  • Have evidence of active or latent tuberculosis (TB) as documented by a positive PPD test

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Paul Koros, RN, Site Manager
NEA Baptist Clinic - Clinical Research Center
416 E. Washington, Suite C
Jonesboro, AR 72401
Phone: 870-934-1006
Fax: 870-934-1008

View Map

Research Center Information: NEA Baptist Clinic - Clinical Research Center

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 177055

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.